Imidazopyridiner
Filtrerede søgeresultater
Pumaprazole, MedChemExpress
MedChemExpress Pumaprazole is a reversible proton pump antagonist.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Pumaprazole |
|---|---|
| Formel vægt | 338.4 |
| Opløselighedsinformation | DMSO : 100 mg/mL (295.51 mM; Need ultrasonic) |
| Procent renhed | 99.9% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 338.4 |
| CAS | 158364-59-1 |
| Synonym | BY-841 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(OC)NC1=CC=CC(C)=C1CNC2=CC=CN3C2=NC(C)=C3C |
| Renhedsgrad noter | Research |
| Molekylær formel | C19H22N4O2 |
| Til brug med (applikation) | COVID-19-immunoregulation |
Linaprazan, MedChemExpress
MedChemExpress Linaprazan (AZD0865) inhibits gastric H+,K+-ATPase by K+-competitive binding.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Linaprazan |
|---|---|
| Formel vægt | 366.46 |
| Opløselighedsinformation | DMSO : ≥ 35 mg/mL (95.51 mM) |
| Procent renhed | 98.8% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 366.46 |
| CAS | 248919-64-4 |
| Synonym | AZD0865 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=CN2C(C(NCC3=C(C)C=CC=C3C)=C1)=NC(C)=C2C)NCCO |
| Renhedsgrad noter | Research |
| Molekylær formel | C21H26N4O2 |
| Til brug med (applikation) | Cancer-programmed cell death |
IRAK inhibitor 1, MedChemExpress
MedChemExpress IRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC50 of 216 nM, is poorly active against JNK-1 and JNK-2 with IC50 of 3.801 μM, and >10 μM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | IRAK inhibitor 1 |
|---|---|
| Formel vægt | 293.37 |
| Opløselighedsinformation | DMSO : 16.67 mg/mL (56.82 mM; Need ultrasonic) |
| Procent renhed | 98.05% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 293.37 |
| CAS | 1042224-63-4 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | C1(C2=CN=C3N2C=CC=C3)=CC=CC(NC4CCNCC4)=N1 |
| Renhedsgrad noter | Research |
| Molekylær formel | C17H19N5 |
| Til brug med (applikation) | COVID-19-immunoregulation |
Savolitinib, MedChemExpress
MedChemExpress Savolitinib (AZD-6094) is a potent, highly selective, and orally bioavailable c-Met inhibitor with IC50 s of 5 nM and 3 nM for c-Met and p-Met, respectively. Savolitinib (AZD-6094) selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. Antineoplastic activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Savolitinib |
|---|---|
| Formel vægt | 345.36 |
| Opløselighedsinformation | DMSO : 25 mg/mL (72.39 mM; Need ultrasonic) |
| Procent renhed | 98.45% |
| Fysisk form | Solid |
| Farve | Off-White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 345.36 |
| CAS | 1313725-88-0 |
| Synonym | Volitinib HMPL-504 AZD-6094 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | CN1N=CC(C2=CN=C3C(N([C@H](C4=CN5C(C=C4)=NC=C5)C)N=N3)=N2)=C1 |
| Renhedsgrad noter | Research |
| Molekylær formel | C17H15N9 |
| Til brug med (applikation) | Cancer-Kinase/protease |
PDE10-IN-1, MedChemExpress
MedChemExpress PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | PDE10-IN-1 |
|---|---|
| Formel vægt | 369.42 |
| Opløselighedsinformation | DMSO : 2 mg/mL (5.41 mM; Need ultrasonic) |
| Procent renhed | 97.82% |
| Fysisk form | Solid |
| Farve | Earth Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 369.42 |
| CAS | 1516896-09-5 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | CC1=C([C@H]2[C@H](C3=NN4C(C(C)=NC=C4C)=N3)C2)N=C5C6=C(N=CC=C6)C=CN51 |
| Renhedsgrad noter | Research |
| Molekylær formel | C21H19N7 |
| Til brug med (applikation) | Neuroscience-Neuromodulation |
CXCR7 modulator 2, MedChemExpress
MedChemExpress CXCR7 modulator 2 is a modulator of C-X-C Chemokine Receptor Type 7 (CXCR7), with a Ki of 13 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | CXCR7 modulator 2 |
|---|---|
| Formel vægt | 522.68 |
| Opløselighedsinformation | DMSO : 250 mg/mL (478.30 mM; Need ultrasonic) |
| Procent renhed | 98.39% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 522.68 |
| CAS | 2227426-37-9 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C([C@@H]1[C@H](O2)CC[C@H]2C1)N3CCC([C@H](CC(N)=O)N4CCCN(C5=C(CC)C=CN6C5=NC=C6)CC4)CC3 |
| Renhedsgrad noter | Research |
| Molekylær formel | C29H42N6O3 |
| Til brug med (applikation) | Neuroscience-Neuromodulation |
Dipraglurant, MedChemExpress
MedChemExpress Dipraglurant (ADX48621) is a potent, selective, orally active and brain penetrant mGluR5 negative allosteric modulator (NAM), with an IC50 of 21 nM. Dipraglurant can reduce Levodopa-induced dyskinesia (LID) in vivo.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Dipraglurant |
|---|---|
| Formel vægt | 265.29 |
| Opløselighedsinformation | DMSO : ≥ 40 mg/mL (150.78 mM) |
| Procent renhed | 95.95% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 265.29 |
| CAS | 872363-17-2 |
| Synonym | ADX48621 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | FC1=CN2C(C=C1)=NC(CCC#CC3=NC=CC=C3)=C2 |
| Renhedsgrad noter | Research |
| Molekylær formel | C16H12FN3 |
| Til brug med (applikation) | Neuroscience-Neurodegeneration |
Antitumor agent-3, MedChemExpress
MedChemExpress Antitumor agent-3 is a potent compound which comprises a new imidazopyridine having excellent antitumor activity as an active ingredient.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Antitumor agent-3 |
|---|---|
| Formel vægt | 428.35 |
| Opløselighedsinformation | DMSO : ≥ 59 mg/mL (137.74 mM) |
| Procent renhed | 99.71% |
| Fysisk form | Solid |
| Farve | Off-White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 428.35 |
| CAS | 420126-30-3 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | FC(C1=CC=C(NC2=NC(C3=C(C(F)(F)F)N=C4C=CC=CN43)=CS2)C=C1)(F)F |
| Renhedsgrad noter | Research |
| Molekylær formel | C18H10F6N4S |
| Til brug med (applikation) | Cancer-programmed cell death |
Soraprazan, MedChemExpress
MedChemExpress Soraprazan (BYK61359) is a selective, reversible K-competitive inhibitor of the H,K-ATPase (Ki=6.4 nM), with an IC50 of 0.19 μM in gastric glands. Soraprazan binds to the H,K-ATPase with a Kd of 28.27 nM. Soraprazan shows immediate inhibition of acid secretion and is more than 2000-fold selective for H,K-ATPase over Na,K- and Ca-ATPases.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Soraprazan |
|---|---|
| Formel vægt | 367.44 |
| Opløselighedsinformation | DMSO : ≥ 150 mg/mL (408.23 mM) |
| Procent renhed | 99.69% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 367.44 |
| CAS | 261944-46-1 |
| Synonym | BYK61359 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O[C@@H]1[C@@H](C2=CC=CC=C2)NC3=C(C=CN4C3=NC(C)=C4C)[C@H]1OCCOC |
| Renhedsgrad noter | Research |
| Molekylær formel | C21H25N3O3 |
JK184, MedChemExpress
MedChemExpress JK184 is a potent Hedgehog (Hh) pathway inhibitor with IC50 of 30 nM in mammalian cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | JK184 |
|---|---|
| Sundhedsfare 1 | H302∣H315∣H319∣H335 |
| Formel vægt | 350.44 |
| Opløselighedsinformation | DMSO : ≥ 50 mg/mL (142.68 mM) |
| Procent renhed | 99.37% |
| Fysisk form | Solid |
| Farve | Pink |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 350.44 |
| CAS | 315703-52-7 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | CC1=C(C2=CSC(NC3=CC=C(OCC)C=C3)=N2)N4C=CC=CC4=N1 |
| Renhedsgrad noter | Research |
| Molekylær formel | C19H18N4OS |
| Til brug med (applikation) | Cancer-programmed cell death |
Serabelisib, MedChemExpress
MedChemExpress Serabelisib (MLN1117) is a selective p110α inhibitor with an IC50 of 15 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Serabelisib |
|---|---|
| Formel vægt | 363.37 |
| Opløselighedsinformation | DMSO : 6.4 mg/mL (17.61 mM; Need ultrasonic and warming) |
| Procent renhed | 98.1% |
| Fysisk form | Solid |
| Farve | Gray |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 363.37 |
| CAS | 1268454-23-4 |
| Synonym | MLN1117 INK1117 TAK-117 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=CN=C2C=CC(C3=CC=C(OC(N)=N4)C4=C3)=CN21)N5CCOCC5 |
| Renhedsgrad noter | Research |
| Molekylær formel | C19H17N5O3 |
| Til brug med (applikation) | Cancer-Kinase/protease |
DGAT1-IN-1, MedChemExpress
MedChemExpress DGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of < 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | DGAT1-IN-1 |
|---|---|
| Formel vægt | 551.56 |
| Opløselighedsinformation | DMSO : 20 mg/mL (36.26 mM; Need ultrasonic) |
| Procent renhed | 95.0% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 551.56 |
| CAS | 1449779-49-0 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | OC(C[C@H]1CC[C@H](C2=CC=C(C3=CN4C=C(C(NCC5=CC=C(OC(F)(F)F)C=C5)=O)N=C4C=C3)C=C2)CC1)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C30H28F3N3O4 |
| Til brug med (applikation) | Metabolism-sugar/lipid metabolism |
Olprinone Hydrochloride, MedChemExpress
MedChemExpress Olprinone (Loprinone) Hydrochloride is a potent phosphodiesterase (PDE) 3 inhibitor, with IC50s of 150, 100, 0.35 and 14 μM for PDE1, PDE2, PDE3 and PDE4, respectively. Olprinone Hydrochloride is used for the research of heart failure due to its positive inotropic and vasodilative effects. Anti-inflammatory activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Olprinone Hydrochloride |
|---|---|
| Sundhedsfare 1 | H315∣H319∣H335 |
| Formel vægt | 286.72 |
| Opløselighedsinformation | H2O : ≥ 7.69 mg/mL (26.82 mM) |
| Procent renhed | 99.91% |
| Fysisk form | Solid |
| Farve | Off-White |
| Grad | Research |
| Anbefalet opbevaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molekylvægt (g/mol) | 286.72 |
| CAS | 119615-63-3 |
| Synonym | Loprinone Hydrochloride |
| Holdbarhed | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| SMIL | CC(N1)=C(C=C(C#N)C1=O)C2=CN3C(C=C2)=NC=C3.[H]Cl |
| Renhedsgrad noter | Research |
| Molekylær formel | C14H11ClN4O |
| Til brug med (applikation) | COVID-19-immunoregulation |